Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Three Arms, Randomized, Double-blind Controlled Trial of the Efficacy of Amway Uric Acid Lowering Product on Hyperuricemia

NCT06084585 is registered in ClinicalTrials.gov with Amway (China) R&D Center as lead sponsor.

NCT NCT06084585
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06084585 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Three Arms, Randomized, Double-blind Controlled Trial of the Efficacy of Amway Uric Acid Lowering Product on Hyperuricemia
Lead sponsor
Amway (China) R&D Center
Phase
Not applicable
Overall status
Unknown status
Start date
October 23, 2023
Completion date
March 15, 2024
Enrollment
180 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hyperuricemia